Co-Diagnostics, Inc. Vector Control Products Continue to Gain Acceptance Across the US Salt Lake City, UT, July 30, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples Salt Lake City, UT, July 18, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

Co-Diagnostics, Inc. Launches North American Mosquito Diagnostic Product Salt Lake City, UT, July 11, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. Launches North American Mosquito Diagnostic Product Salt Lake City, Utah – Co-Diagnostics, Inc. (Nasdaq: CODX), a...

Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test SALT LAKE CITY, July 27, 2017 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ:CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for...